These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 24981027)
1. Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials. Moorhouse R; Slack C; Quayle M; Essack Z; Lindegger G BMC Med Ethics; 2014 Jun; 15():51. PubMed ID: 24981027 [TBL] [Abstract][Full Text] [Related]
2. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa. Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900 [TBL] [Abstract][Full Text] [Related]
3. South African Research Ethics Committee Review of Standards of Prevention in HIV Vaccine Trial Protocols. Essack Z; Wassenaar DR J Empir Res Hum Res Ethics; 2018 Jul; 13(3):239-246. PubMed ID: 29631486 [TBL] [Abstract][Full Text] [Related]
4. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa. Mamotte N; Wassenaar D; Koen J; Essack Z BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030 [TBL] [Abstract][Full Text] [Related]
5. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees. Klitzman R Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258 [TBL] [Abstract][Full Text] [Related]
6. Ancillary care in South African HIV vaccine trials: addressing needs, drafting protocols, and engaging community. Slack CM J Empir Res Hum Res Ethics; 2014 Feb; 9(1):83-95. PubMed ID: 24572086 [TBL] [Abstract][Full Text] [Related]
7. The 'over-researched community': An ethics analysis of stakeholder views at two South African HIV prevention research sites. Koen J; Wassenaar D; Mamotte N Soc Sci Med; 2017 Dec; 194():1-9. PubMed ID: 29035778 [TBL] [Abstract][Full Text] [Related]
8. The psychology of "cure" - unique challenges to consent processes in HIV cure research in South Africa. Moodley K; Staunton C; Rossouw T; de Roubaix M; Duby Z; Skinner D BMC Med Ethics; 2019 Jan; 20(1):9. PubMed ID: 30678664 [TBL] [Abstract][Full Text] [Related]
9. "Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa. Thabethe S; Slack C; Lindegger G; Wilkinson A; Wassenaar D; Kerr P; Bekker LG; Mngadi K; Newman PA J Empir Res Hum Res Ethics; 2018 Dec; 13(5):525-536. PubMed ID: 30417754 [TBL] [Abstract][Full Text] [Related]
10. HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives. Moodley K; Staunton C; de Roubaix M; Cotton M AIDS Care; 2016; 28(4):524-7. PubMed ID: 26565595 [TBL] [Abstract][Full Text] [Related]
11. Microbicide research in developing countries: have we given the ethical concerns due consideration? Moodley K BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834 [TBL] [Abstract][Full Text] [Related]
12. Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa. Slack C; Strode A; Fleischer T; Gray G; Ranchod C BMC Med Ethics; 2007 May; 8():5. PubMed ID: 17498316 [TBL] [Abstract][Full Text] [Related]
13. Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidence. Newman PA; Rubincam C Expert Rev Vaccines; 2014 Dec; 13(12):1553-62. PubMed ID: 25174764 [TBL] [Abstract][Full Text] [Related]
14. Community perspectives on the ethical issues surrounding adolescent HIV vaccine trials in South Africa. Jaspan HB; Soka NF; Strode AE; Mathews C; Mark D; Flisher AJ; Wood R; Bekker LG Vaccine; 2008 Oct; 26(45):5679-83. PubMed ID: 18782594 [TBL] [Abstract][Full Text] [Related]
15. HIV vaccine trials: critical issues in informed consent. Lindegger G; Richter LM S Afr J Sci; 2000 Jun; 96():313-7. PubMed ID: 15739286 [TBL] [Abstract][Full Text] [Related]
16. Ethical considerations in HIV prevention and vaccine research in resource-limited settings. Garner SA; Anude CJ; Adams E; Dawson L J Acquir Immune Defic Syndr; 2014 Sep; 67(1):77-83. PubMed ID: 25117930 [TBL] [Abstract][Full Text] [Related]
17. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana. ; Osmanov S AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089 [TBL] [Abstract][Full Text] [Related]
18. Ensuring Access to HIV Prevention Services in South African HIV Vaccine Trials: Correspondence Between Guidelines and Practices. Essack Z Public Health Ethics; 2014 Jul; 7(2):195-206. PubMed ID: 25031609 [TBL] [Abstract][Full Text] [Related]
19. HIV Vaccine Trial participation in South Africa - an ethical assessment. Moodley K J Med Philos; 2002 Apr; 27(2):197-215. PubMed ID: 11961697 [TBL] [Abstract][Full Text] [Related]
20. Ethical considerations for involving adolescents in biomedical HIV prevention research. Nakalega R; Akello C; Gati B; Nakabiito C; Nolan M; Kamira B; Etima J; Nakyanzi T; Kemigisha D; Nanziri SC; Nanyonga S; Nambusi MJ; Mulumba E; Biira F; Nabunya HK; Akasiima SA; Nansimbe J; Maena J; Babirye JA; Ngure K; Mujugira A BMC Med Ethics; 2021 Sep; 22(1):127. PubMed ID: 34556099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]